DexCom Inc.

DXCM ·Healthcare, Medical Devices, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
ARS Apr 15, 2026 ARS
DEFA14A Apr 15, 2026 DEFA14A
DEF 14A Apr 15, 2026 DEF 14A
144 Apr 15, 2026
SCHEDULE 13G/A Mar 26, 2026
4 Mar 18, 2026 FORM 4
144 Mar 16, 2026
4 Mar 10, 2026 FORM 4
4 Mar 10, 2026 FORM 4
4 Mar 10, 2026 FORM 4
4 Mar 10, 2026 FORM 4
4 Mar 10, 2026 FORM 4
4 Mar 10, 2026 FORM 4
8-K Mar 2, 2026 8-K
4 Feb 26, 2026 FORM 4
3 Feb 26, 2026 FORM 3
8-K Feb 26, 2026 8-K
4 Feb 17, 2026 FORM 4
10-K Feb 12, 2026 10-K
8-K Feb 12, 2026 8-K
144 Feb 12, 2026
4 Feb 2, 2026 FORM 4
4 Feb 2, 2026 FORM 4
4 Feb 2, 2026 FORM 4
4 Feb 2, 2026 FORM 4
← Newer Page 4 of 106 · 2642 filings Older →